- Home
- PRPL vs PETS Comparison
PRPL vs PETS Comparison
Compare PRPL & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPL
- PETS
- Stock Information
- Founded
- PRPL 2010
- PETS 1996
- Country
- PRPL United States
- PETS United States
- Employees
- PRPL N/A
- PETS N/A
- Industry
- PRPL Home Furnishings
- PETS Retail-Drug Stores and Proprietary Stores
- Sector
- PRPL Consumer Discretionary
- PETS Consumer Staples
- Exchange
- PRPL Nasdaq
- PETS Nasdaq
- Market Cap
- PRPL 100.6M
- PETS 118.8M
- IPO Year
- PRPL N/A
- PETS N/A
- Fundamental
- Price
- PRPL $0.91
- PETS $4.97
- Analyst Decision
- PRPL Buy
- PETS Sell
- Analyst Count
- PRPL 4
- PETS 2
- Target Price
- PRPL $2.53
- PETS $3.50
- AVG Volume (30 Days)
- PRPL 347.4K
- PETS 324.5K
- Earning Date
- PRPL 11-04-2024
- PETS 02-06-2025
- Dividend Yield
- PRPL N/A
- PETS N/A
- EPS Growth
- PRPL N/A
- PETS N/A
- EPS
- PRPL N/A
- PETS N/A
- Revenue
- PRPL $504,838,000.00
- PETS $259,343,000.00
- Revenue This Year
- PRPL N/A
- PETS N/A
- Revenue Next Year
- PRPL $2.21
- PETS $3.36
- P/E Ratio
- PRPL N/A
- PETS N/A
- Revenue Growth
- PRPL N/A
- PETS N/A
- 52 Week Low
- PRPL $0.69
- PETS $2.90
- 52 Week High
- PRPL $2.33
- PETS $7.79
- Technical
- Relative Strength Index (RSI)
- PRPL 47.38
- PETS 46.03
- Support Level
- PRPL $0.84
- PETS $5.41
- Resistance Level
- PRPL $0.99
- PETS $6.85
- Average True Range (ATR)
- PRPL 0.06
- PETS 0.50
- MACD
- PRPL -0.01
- PETS -0.11
- Stochastic Oscillator
- PRPL 33.30
- PETS 21.99
About PRPL Purple Innovation Inc.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms, and other products. It sells its products through online channels, traditional wholesale partners and third-party online retailers.
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.